Nuvonis Technologies offers GMP-grade cell lines that are revolutionizing cultivated meat production by addressing critical regulatory hurdles. These cell lines are manufactured under Good Manufacturing Practice standards, thoroughly tested, and strictly adhere to pharmacopeial regulations, providing comprehensive documentation and traceable provenance. Nuvonis' cell lines can be grown in various cultivation systems, ensuring scalability and compatibility with industrial production processes, making them a valuable resource for novel food companies seeking market approval.

By providing high-quality, readily available cell lines and offering tailored cell line development and banking services, Nuvonis Technologies helps navigate complex regulatory requirements with greater efficiency and confidence, accelerating the path from concept to market. Based in Vienna, Austria, Nuvonis specializes in advancing biopharmaceutical and cellular agriculture development, streamlining the entire production journey from research to market entry. In a rapidly evolving landscape of cultivated meat production, Nuvonis is leading the way in providing safe, sustainable protein sources for the global food supply.